[HTML] springer.com

[HTML][HTML] Nanoparticles: oral delivery for protein and peptide drugs

S Cao, S Xu, H Wang, Y Ling, J Dong, R Xia, X Sun - Aaps Pharmscitech, 2019 - Springer
Protein and peptide drugs have many advantages, such as high bioactivity and specificity,
strong solubility, and low toxicity. Therefore, the strategies for improving the bioavailability of …
被引用次数：240 相关文章

Nanoparticles: Oral Delivery for Protein and Peptide Drugs

SJ Cao, S Xu, HM Wang, Y Ling, J Dong… - AAPS …, 2019 - pubmed.ncbi.nlm.nih.gov
Protein and peptide drugs have many advantages, such as high bioactivity and specificity,
strong solubility, and low toxicity. Therefore, the strategies for improving the bioavailability of …

Nanoparticles: Oral Delivery for Protein and Peptide Drugs.

S Cao, S Xu, H Wang, Y Ling, J Dong… - AAPS …, 2019 - search.ebscohost.com
Protein and peptide drugs have many advantages, such as high bioactivity and specificity,
strong solubility, and low toxicity. Therefore, the strategies for improving the bioavailability of …

[引用][C] Nanoparticles: Oral Delivery for Protein and Peptide Drugs

S Cao, S Xu, H Wang, Y Ling, J Dong, R Xia… - AAPS PharmSciTech, 2019 - cir.nii.ac.jp

Nanoparticles: Oral Delivery for Protein and Peptide Drugs.

SJ Cao, S Xu, HM Wang, Y Ling, J Dong… - AAPS …, 2019 - europepmc.org
Protein and peptide drugs have many advantages, such as high bioactivity and specificity,
strong solubility, and low toxicity. Therefore, the strategies for improving the bioavailability of …
[HTML] nih.gov

[HTML][HTML] Nanoparticles: Oral Delivery for Protein and Peptide Drugs

S Cao, S Xu, H Wang, Y Ling, J Dong, R Xia… - AAPS …, 2019 - ncbi.nlm.nih.gov
Protein and peptide drugs have many advantages, such as high bioactivity and specificity,
strong solubility, and low toxicity. Therefore, the strategies for improving the bioavailability of …